[HTML][HTML] Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin
Y Nan - Oncology reports, 2019 - spandidos-publications.com
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin
Y Nan - Oncology reports, 2019 - pubmed.ncbi.nlm.nih.gov
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
[HTML][HTML] Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin
Y Nan - Oncology Reports, 2019 - spandidos-publications.com
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
Lung carcinoma therapy using epidermal growth factor receptor-targeted lipid polymeric nanoparticles co-loaded with cisplatin and doxorubicin
Y Nan - Oncology Reports, 2019 - search.proquest.com
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
Lung carcinoma therapy using epidermal growth factor receptor-targeted lipid polymeric nanoparticles co-loaded with cisplatin and doxorubicin
Y Nan - Oncology Reports, 2019 - hero.epa.gov
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
Lung carcinoma therapy using epidermal growth factor receptor-targeted lipid polymeric nanoparticles co-loaded with cisplatin and doxorubicin.
Y Nan - Oncology Reports, 2019 - go.gale.com
The rate of lung cancer in tuberculosis (TB) patients is 7-30% higher than that in healthy
individuals. TB also predicts an increased long-term risk of cancer (1). Non-small cell lung …
individuals. TB also predicts an increased long-term risk of cancer (1). Non-small cell lung …
Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin.
Y Nan - Oncology Reports, 2019 - europepmc.org
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin
YAN NAN - ONCOLOGY REPORTS, 2019 - ingentaconnect.com
The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …